Benzoxadiazoles
Aobchem (4-Isobutoxynaphthalen-1-yl)boronic acid | 97% | C14H17BO3 | 1g
(4-Isobutoxynaphthalen-1-yl)boronic acid | 97% | C14H17BO3 | 1g
Aobchem 3-Bromo-2-formylthiophene-5-boronic acid | ≥97% | CAS 1451393-26-2 | C5H4BBrO3S | 1g
3-Bromo-2-formylthiophene-5-boronic acid | ≥97% | CAS 1451393-26-2 | C5H4BBrO3S | 1g
Aobchem 5-Chloro-2-ethoxypyridine-3-boronic acid pinacol ester | ≥95% | CAS 2121511-53-1 | C13H19BClNO3 | 250mg
5-Chloro-2-ethoxypyridine-3-boronic acid pinacol ester | ≥95% | CAS 2121511-53-1 | C13H19BClNO3 | 250mg
Aobchem 5-Chloro-2-ethoxypyridine-3-boronic acid pinacol ester | ≥95% | CAS 2121511-53-1 | C13H19BClNO3 | 500mg
5-Chloro-2-ethoxypyridine-3-boronic acid pinacol ester | ≥95% | CAS 2121511-53-1 | C13H19BClNO3 | 500mg
Aobchem 5-Chloro-2-ethoxypyridine-4-boronic acid | ≥97% | CAS 1882041-03-3 | C7H9BClNO3 | 10g
5-Chloro-2-ethoxypyridine-4-boronic acid | ≥97% | CAS 1882041-03-3 | C7H9BClNO3 | 10g
Aobchem 5-Chloro-2-ethoxypyridine-4-boronic acid pinacol ester | 97% | CAS 2121513-05-9 | C13H19BClNO3 | 1g
5-Chloro-2-ethoxypyridine-4-boronic acid pinacol ester | 97% | CAS 2121513-05-9 | C13H19BClNO3 | 1g
Aobchem B-[4-(1-Phenylethoxy)phenyl]boronic acid | 95% | CAS 938443-42-6 | C14H15BO3 | 250mg
B-[4-(1-Phenylethoxy)phenyl]boronic acid | 95% | CAS 938443-42-6 | C14H15BO3 | 250mg
Aobchem 5-Chloro-2-ethoxypyridine-4-boronic acid | ≥97% | CAS 1882041-03-3 | C7H9BClNO3 | 5g
5-Chloro-2-ethoxypyridine-4-boronic acid | ≥97% | CAS 1882041-03-3 | C7H9BClNO3 | 5g
Aobchem 5-Chloro-2-ethoxypyridine-4-boronic acid | ≥97% | CAS 1882041-03-3 | C7H9BClNO3 | 500mg
5-Chloro-2-ethoxypyridine-4-boronic acid | ≥97% | CAS 1882041-03-3 | C7H9BClNO3 | 500mg
Medchemexpress LLC Nbd-556 | 333353-44-9 | 99.6% | C17H24ClN3O2 | 1 ML
NBD-556, a CD4 mimetic, is a potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction. It demonstrates potent cell fusion and virus-cell fusion inhibitory activity at low micromolar levels.
- Potent HIV-1 entry inhibitor
- Blocks gp120-CD4 interaction
- Shows potent cell fusion and virus-cell fusion inhibitory activity
- Inhibits HIV-1 envelope-mediated virus-cell and cell-cell fusion
- Inhibits infection of MT-2 cells by laboratory-adapted HIV-1 strains
- Inhibits CD4-dependent virus in a dose-dependent manner
Medchemexpress LLC C6 NBD glucosylceramide | 94885-03-7 | MFCD00870345 | 98.0% | 737.88 g/mol | C36H59N5O11 | 500 UG
C6 NBD glucosylceramide is a fluorescently labeled short-chain glucosylceramide used as a probe to study sphingolipid metabolism, intracellular trafficking, and glucosylceramide synthase activity. It is provided as a yellow-orange solid for research use and exhibits strong NBD fluorescence for sensitive detection in biochemical and cell-based assays.
- Fluorescent probe with excitation 466 nm and emission 535 nm.
- High purity suitable for biochemical assays.
- Short-chain analog for efficient cellular uptake.
- Stable solid; store protected from moisture and light.
- Compact 500 μg format for small-scale experiments.
Medchemexpress LLC Apelin-16, human, bovine acetate | 99.8% | 2010.37 (free base) | 5 MG
Apelin-16, human, bovine acetate is a biologically active peptide. Apelin is the endogenous ligand for the G-protein-coupled APJ receptor. It is produced as a pre-proprotein of 77 amino acids, and Apelin-16 is one of its active fragments.
- Biologically active peptide
- Endogenous ligand for the G-protein-coupled APJ receptor
- Derived from a pre-proprotein of 77 amino acids
- Active fragment of Apelin
Medchemexpress LLC NBD-556 | 333353-44-9 | 99.6% | C17H24ClN3O2 | 25 MG
NBD-556 is a CD4 mimetic and a potent HIV-1 entry inhibitor. It functions by blocking the gp120-CD4 interaction. NBD-556 exhibits potent cell fusion and virus-cell fusion inhibitory activity at low micromolar levels.
- Inhibits HIV-1 envelope-mediated virus-cell and cell-cell fusion.
- Inhibits the infection of MT-2 cells by laboratory-adapted HIV-1 strains.
- Inhibits CD4-dependent virus in a dose-dependent manner.
Medchemexpress LLC NBD-14270 | 2411819-82-2 | 99.53% | 425.43 | 1 ML
NBD-14270, a pyridine analogue, is a potent HIV-1 entry antagonist with an IC50 of 180 nM against 50 HIV-1 Env-pseudotyped viruses. It binds to HIV-1 gp120 and demonstrates potent antiviral activity, with low cytotoxicity (CC50>100 μM).
- Potent HIV-1 entry antagonist
- IC50 of 180 nM against 50 HIV-1 Env-pseudotyped viruses
- Binds to HIV-1 gp120
- Demonstrates potent antiviral activity
- Low cytotoxicity (CC50>100 μM)
Apexbio Technology LLC NBD-F 29270-56-2 100mg
NBD-F (29270-56-2) is a fluorescent derivatization reagent utilized for the detection and quantification of amino acids and low molecular weight amines NBD-F exerts its activity by selectively reacting with primary and secondary amines through its benzofurazan structure forming fluorescent conjugates detectable in biological samples Based on these properties NBD-F holds research potential in biochemical analysis metabolic profiling disease pathology investigation and fluorescent labeling in proteomics and molecular biology